Biostage, Inc. | Business Contracts

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on January 12, 2023)

Form of Warrant Agency Agreement between Biostage, Inc. and Computershare (Filed With SEC on October 27, 2022)

Preferred Issuance Agreement (Filed With SEC on April 28, 2022)

Form of Underwriters Warrant (Filed With SEC on October 27, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on October 27, 2022)

Form of Underwriting Agreement (Filed With SEC on October 27, 2022)

Employment Agreement between Biostage, Inc. and Joseph L. Damasio, Jr (Filed With SEC on August 10, 2022)

Form of Securities Purchase Agreement (Filed With SEC on May 13, 2022)

Form of Warrant (Filed With SEC on May 13, 2022)

Employment Agreement between Biostage, Inc. and David Green (Filed With SEC on November 30, 2021)

Form of Securities Purchase Agreement, dated as of November 26, 2021 (Filed With SEC on November 30, 2021)

Form of Warrant (Filed With SEC on November 30, 2021)

Form of Securities Purchase Agreement, dated as of September 1, 2021 (Filed With SEC on September 8, 2021)

Form of Warrant (Filed With SEC on September 8, 2021)

Form of Warrant (Filed With SEC on June 22, 2021)

Form of Securities Purchase Agreement, dated as of June 17, 2021 (Filed With SEC on June 22, 2021)

Description of Securities (Filed With SEC on March 27, 2020)

Offer Letter by and between Biostage, Inc. and Peter Chakoutis, dated as of March 24, 2020 (Filed With SEC on March 24, 2020)

Separation and Release Agreement by and between Biostage, Inc. and James McGorry (Filed With SEC on February 7, 2020)

Securities Purchase Agreement dated as of December 31, 2019 (Filed With SEC on January 2, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on January 2, 2020)

Form of Amendment to Common Stock Purchase Warrant (Filed With SEC on December 18, 2019)

Form of Warrant (Filed With SEC on June 17, 2019)

Securities Purchase Agreement between the Company and Junli He, dated as of June 12, 2019 (Filed With SEC on June 17, 2019)

Separation and Release Agreement by and between Biostage, Inc. and Thomas McNaughton (Filed With SEC on June 17, 2019)

2013 Equity Incentive Plan, as amended (Filed With SEC on March 29, 2019)

Director Compensation Arrangements (Filed With SEC on March 29, 2019)

Form of Warrant (Filed With SEC on January 3, 2018)

Biostage, Inc. (34)